Record-setting Bio-Silicon Chip is first to create Synthetic DNA at IT Scale for Molecular Computing solutions addressing growing demands of the AI Era SAN FRANCISCO — AtlasBase today announced its molecular computing platform, powered by Thalia, a new scalable chip that delivers petabyte-scale synthetic DNA creation. With 5.6 billion electro-chemical synthesis sites, Thalia represents a […]

Industry’s First End-to-End Flow Cytometry Platform Covering Panel Design Through Data Analysis FREMONT, Calif. — Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the expansion of its Cytek® Cloud digital ecosystem with a new Cloud Analysis tool, establishing the industry’s first end-to-end platform that integrates the entire flow cytometry workflow from panel […]

New cGMP-ready media and feed panel helps developers rapidly identify high-performing combinations, with study results demonstrating up to 73% higher titer versus benchmark catalog media and feeds and up to 202% higher peak viable cell density compared with benchmark products tested Key facts Product: Gibco™ CHO-K1 Catalog Panel Media and Feed Category: Basal and feed […]

ROCKVILLE, Md. — MaxCyte, Inc. (Nasdaq: MXCT), a leading cell engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it has appointed Sidharth Kapileshwar as Chief Corporate Development Officer. “Sidharth has a proven track record of building and scaling corporate development functions inside some […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) (“Bio-Techne”), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve and adopt the definitive agreement under which Merck KGaA, Darmstadt, Germany proposes to acquire Bio-Techne (the “Merger Agreement”) at a Special Meeting of Shareholders held today. “We are grateful to our […]

The acquisition will help expand AVS Bio’s biomaterials offering and ecommerce capabilities NORWICH, Conn. — AVS Bio (the “Company”), a leading global provider of critical inputs and services for the bioprocessing and biologics industries, today announced it has acquired Biorbyt Ltd. (“Biorbyt”), a global supplier of high-quality bio-reagents, antibodies, proteins, and other biomaterials for life […]

New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise Regional hub will support researchers and organizations across the DACH and broader EMEA regions Center strengthens collaboration, training and innovation within Europe’s life sciences community MINNEAPOLIS and DÜSSELDORF, Germany — Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic […]

New portfolio combines high-performance cell culture media, molecule-specific CQA optimization, and integrated CDMO capabilities to help biosimilar developers accelerate the path to analytical similarity and improve process economics. Pleasanton, Calif. – OPM Biosciences, a cell culture media and bioprocess solutions company, today announced two new offerings that extend its OPM-CHO™ platform into biosimilar development and […]

Former Olink Proteomics President brings extensive life-science tools leadership experience, having helped lead Olink through its $3.1 billion acquisition by Thermo Fisher Scientific Co-founder and former CEO Dr Michael Chen transitions to Chief Scientific and Business Officer Cambridge, UK, and Boston, MA, USA — Nuclera, the biotechnology company enabling access to innovative protein technologies, today announced […]

HOUSTON — Elabscience® Bionovation Inc. (“Elabscience®” or “the Company”) launched EasySort™ Mouse CD4 Nanobeads on September 22, 2026, the Company’s first magnetic bead product for positive cell selection, designed to enrich mouse CD4+ cells for basic research. The product combines dextran-coated superparamagnetic beads measuring less than 40nm with high-affinity antibodies developed by Elabscience®. Internal validation showed […]